We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
27 hedge funds and large institutions have $55.1M invested in ADMA Biologics in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
225% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 4
17% more funds holding
Funds holding: 23 → 27 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
19% less capital invested
Capital invested by funds: $67.9M → $55.1M (-$12.8M)
Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
5
Increased
13
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$1.5M |
| 2 |
BC
Broadfin Capital
New York
|
+$1.04M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$875K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$700K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$280K |
Top Sellers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$28.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$21.2K |
| 3 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$19.9K |
| 4 |
Morgan Stanley
New York
|
-$2.02K |
